Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research whether it be developing next-generation drugs, the next major advancement in agriculture or fuel to move the world...

Press Releases
December 20, 2024
Today the dispute settlement panel formed under the United States-Mexico-Canada Agreement (USMCA) issued a final ruling related to Mexico's restrictions on the importation of genetically modified (GM) corn. In response, John Crowley, President and CEO of the Biotechnology Innovation…
December 17, 2024
John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), today released the following statement ahead of an expected vote in the U.S. House of Representatives on a year-end government funding bill that includes many urgent and bipartisan health care and agricultural…
December 9, 2024
Today, the Biotechnology Innovation Organization (BIO) named Sarah Alspach as its new executive vice president and chief communications officer. Alspach, a communications veteran, will join BIO’s senior leadership team. Her first day will be December 9.“Sarah brings remarkable passion, experience,…
BIO Advocacy Toolkit

We’ve made it easier for you to access information and share content about biotechnology and prescription medicines. Learn more about dozens of topics and then share information you discover on Twitter, Facebook, and LinkedIn.

BIO Advocate Toolkit
Become an Advocate for Biotechnology
Become an Advocate for Biotechnology

Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.